We then preliminarily detected ADAM9 expression at the protein level in the tissue samples of 39 cases of resected stage I–III NSCLC (16), and revealed that ADAM9 was highly expressed in NSCLC tissue, suggesting that ADAM9 may be important in NSCLC growth, invasion and metastasis. The gene discussed is ADAM9; the disease is non-small cell lung carcinoma.